S
SeqWell
SeqWell’s new Illumina-compatible plexWell Library Preparation technology
About SeqWell
SeqWell is a pioneering company in the genomics sector, specializing in Next-Generation Sequencing (NGS) library preparation technology. Founded in 2014, the company aims to revolutionize DNA sequencing by providing scalable and efficient library prep solutions. SeqWell's core product, the TnX transposase, allows for custom loading with adapters of choice, enabling researchers to achieve faster and more accurate sequencing results. The company serves a diverse clientele, including academic researchers, biotech firms, and pharmaceutical companies, who require high-performance sequencing for various applications such as genetic research, diagnostics, and drug development. SeqWell operates in the global genomics market and generates revenue through the sale of its proprietary NGS library prep kits and related services. The business model focuses on innovation and customer responsiveness, ensuring that their products simplify sequencing workflows and reduce time to data. SeqWell's commitment to equal employment opportunities and a collaborative corporate culture further strengthens its market position.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Beverly, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 63.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Sep 2023 | $3.4M | $45M | Undisclosed | ↗ |
| SERIES C✓Equity / VC | Mar 2022 | $7M | $45M | BroadOak Capital Partners · Codexis · Research Corporation Technologies | ↗ |
Growth signals
Latest recorded traffic for SeqWell is 10K monthly website visits, up 19% over the last three months. SeqWell's team declined 7.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Research Corporation Technologies- BPBroadOak Capital Partners
Series B and later1 investor entered at this stage
Codexis
Other known investors1 additional known investor
North Shore InnoVentures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SeqWell on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SeqWell’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.